David D. Eisenstat, M.D., M.A., F.R.C.P.C

Pediatrics and Medical Genetics University of Alberta, Edmonton, Alberta, Canada 
CNS germinoma, GBM, BNIP3
"David Eisenstat"
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Ospina PA, McComb A, Pritchard-Wiart LE, et al. (2021) Physical therapy interventions, other than general physical exercise interventions, in children and adolescents before, during and following treatment for cancer. The Cochrane Database of Systematic Reviews. 8: CD012924
Middleton J, Black K, Ghosh S, et al. (2021) Indirect costs associated with out-of-country referral for proton therapy: a survey of adult and pediatric patients in Alberta, Canada. Bmc Health Services Research. 21: 683
Walker H, Khuong Quang DA, Campbell M, et al. (2021) Growth hormone and targeted oncological agents: Are we stopping children with brain tumours from reaching their true height potential? Journal of Paediatrics and Child Health
Sulman EP, Eisenstat DD. (2021) World Cancer Day 2021 - Perspectives in Pediatric and Adult Neuro-Oncology. Frontiers in Oncology. 11: 659800
Issa AM, Aboushawareb SA, Eisenstat DD, et al. (2021) Deliberations about clinical pharmacogenetic testing in pediatric oncology. Personalized Medicine
Maayah ZH, Alam AS, Takahara S, et al. (2021) Resveratrol reduces cardiac NLRP3-inflammasome activation and systemic inflammation to lessen doxorubicin-induced cardiotoxicity in juvenile mice. Febs Letters
Wu HH, Wang B, Armstrong SR, et al. (2021) Hsp70 acts as a fine-switch that controls E3 ligase CHIP-mediated TAp63 and ΔNp63 ubiquitination and degradation. Nucleic Acids Research
Abou Zeinab R, Wu HH, Abuetabh Y, et al. (2021) Pirh2, an E3 Ligase, Regulates the AIP4-p73 Regulatory Pathway by Modulating AIP4 Expression and Ubiquitination. Carcinogenesis
Bennett J, Erker C, Lafay-Cousin L, et al. (2020) Canadian Pediatric Neuro-Oncology Standards of Practice. Frontiers in Oncology. 10: 593192
Nobre L, Zapotocky M, Ramaswamy V, et al. (2020) Outcomes of BRAF V600E Pediatric Gliomas Treated With Targeted BRAF Inhibition. Jco Precision Oncology. 4
See more...